Angamaly Drug Distributors Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 5.00 M
as on 12-12-2024
- Company Age 3 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 Cr
as on 12-12-2024
- Revenue 801.68%
(FY 2023)
- Profit -390.50%
(FY 2023)
- Ebitda 48.80%
(FY 2023)
- Net Worth -87.65%
(FY 2023)
- Total Assets 70.70%
(FY 2023)
About Angamaly Drug Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.50 Cr.
Sidharth Ram and Priya Ram serve as directors at the Company.
- CIN/LLPIN
U24299KL2021PTC072656
- Company No.
072656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Nov 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Angamaly Drug Distributors?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sidharth Ram  | Director | 25-Mar-2022 | Current |
| Priya Ram | Director | 30-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Angamaly Drug Distributors.
Angamaly Drug Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 801.68% increase. The company also saw a substantial fall in profitability, with a 390.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 87.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angamaly Drug Distributors?
In 2023, Angamaly Drug Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gosree Insurance Broking Services Private LimitedActive 8 years 4 monthsSidharth Ram is a mutual person
Leo Pharma Distributors Private LimitedActive 12 years 3 monthsSidharth Ram and Priya Ram are mutual person
- Ram Nivas Resorts And Estates Private LimitedActive 17 years 8 months
Sidharth Ram and Priya Ram are mutual person
- Leo Supply Chain Management Private LimitedActive 12 years 3 months
Sidharth Ram and Priya Ram are mutual person
- Gemini Warehousing And Logistics Private LimitedActive 17 years 11 months
Sidharth Ram and Priya Ram are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2022 | ₹4.50 Cr | Open |
How Many Employees Work at Angamaly Drug Distributors?
Angamaly Drug Distributors has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angamaly Drug Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angamaly Drug Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
